Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study
两种靶向Tau蛋白的活性免疫疗法ACI-35.030和JACI-35.054在早期阿尔茨海默病患者中的安全性和免疫原性：一项1b/2a期、多中心、双盲、随机、安慰剂对照研究
期刊:EBioMedicine
影响因子:10.8
doi:10.1016/j.ebiom.2025.105940
Sol, Olivier; Mermoud, Julien; Hallikainen, Merja; Kurl, Sudhir; Rinne, Juha; Dautzenberg, Paul; Vijverberg, Everard G B; Mummery, Catherine; Börjesson-Hanson, Anne; Jonsson, Michael; Ritchie, Craig; Pennington, Catherine; Vukicevic, Marija; Gollwitzer, Eva; Fiorini, Emma; Hickman, David T; Hliva, Valérie; Gray, Julian; Gerasymchuk, Viktoriia; Wagg, Jonathan; Fournier, Nicolas; Lê, Bénédicte; Kezic, Iva; Steukers, Lennert; Triana-Baltzer, Gallen; Theunis, Clara; Streffer, Johannes; Kosco-Vilbois, Marie; Pfeifer, Andrea; Scheltens, Philip
